Evidence map›Paper›PMID 36270280›Full record

ArticleStem cell reports2022

Human primed and naïve PSCs are both able to differentiate into trophoblast stem cells.

Sergey Viukov, Tom Shani, Jonathan Bayerl, Alejandro Aguilera-Castrejon, Bernardo Oldak, Daoud Sheban, Shadi Tarazi, Yonatan Stelzer, Jacob H Hanna, Noa Novershtern

Open access · goldAbstract read
In one paragraph

Article in Stem cell reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Current Status of Synthetic Mammalian Embryo Models.International journal of molecular sciences · 2024
    Review
  17. Article
  18. Review
  19. Article
  20. Conserved and divergent features of trophoblast stem cells.Journal of molecular endocrinology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Sergey ViukovDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot 7610001, Israel.
Tom ShaniDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot 7610001, Israel.
Jonathan BayerlDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot 7610001, Israel.
Alejandro Aguilera-CastrejonDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot 7610001, Israel.
Bernardo OldakDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot 7610001, Israel.
Daoud ShebanDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot 7610001, Israel.
Shadi TaraziDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot 7610001, Israel.
Yonatan StelzerDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 7610001, Israel.
Jacob H HannaDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot 7610001, Israel. Electronic address: jacob.hanna@weizmann.ac.il.
Noa NovershternDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot 7610001, Israel. Electronic address: noa.novershtern@weizmann.ac.il.
Weizmann Institute of Science · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The recent derivation of human trophoblast stem cells (TSCs) from placental cytotrophoblasts and blastocysts opened opportunities for studying the development and function of the human placenta. Recent reports have suggested that human naïve, but not primed, pluripotent stem cells (PSCs) retain an exclusive potential to generate TSCs. Here we report that, in the absence of WNT stimulation, transforming growth factor β (TGF-β) pathway inhibition leads to direct and robust conversion of primed human PSCs into TSCs. The resulting primed PSC-derived TSC lines exhibit self-renewal, can differentiate into the main trophoblast lineages, and present RNA and epigenetic profiles that are indistinguishable from recently established TSC lines derived from human placenta, blastocysts, or isogenic human naïve PSCs expanded under human enhanced naïve stem cell medium (HENSM) conditions. Activation of nuclear Yes-associated protein (YAP) signaling is sufficient for this conversion and necessary for human TSC maintenance. Our findings underscore a residual plasticity in primed human PSCs that allows their in vitro conversion into extra-embryonic trophoblast lineages.

Indexed as

Pluripotent Stem CellsTrophoblastsBlastocystCell DifferentiationFemaleHumansPlacentaPregnancyextra-embryonic lineagenaïve pluripotencySEMsstem-cell-derived embryo modelssynthetic embryoidstrophoblast stem cells (TSCs)YAP signaling

Identifiers

PMID36270280
PMCPMC9669397
OpenAlexW4306956359

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.